Literature DB >> 24376326

Septic shock caused by Klebsiella oxytoca: An autopsy case and a survival case with driving Extracorporeal Membrane Oxygenation.

S Hagiwara1, M Murata1, M Aoki1, M Kaneko1, K Oshima1.   

Abstract

We report two cases of Klebsiella oxytoca bacteremia. Case 1 was a 56-year-old man who was transferred to our hospital by ambulance due to diarrhea and general fatigue. On arrival, he was clearly conscious. However he was in septic shock. We injected broad spectrum antibacterial agents and started intensive care. Though intensive care included continuous hemodiafiltration (CHDF), he died 22 hours after admission. Case 2 was a 69-year-old man with a history of gastrectomy for gastric cancer. He had been admitted to a previous hospital due to ileus. His ileus tube was removed on the eighth day, and he then developed a fever of 38 ºC on the following day. He went into shock and became unconscious; he was therefore transferred to our hospital. We diagnosed septic shock and disseminated intravascular coagulation (DIC). We injected broad spectrum antibacterial agents, and recombinant thrombomodulin alpha (rTM). Although he was started in intensive care, his hemodynamics were unstable on the day following admission. Extracorporeal membrane oxygenation (ECMO) and intra-aortic balloon pumping (IABP) were started to maintain his hemodynamics. His condition gradually improved, and he was transferred to the previous hospital for rehabilitation on the 28(th) day. ECMO for septic shock in adults is unusual; however ECMO can be introduced even in patients with severe sepsis under careful monitoring. The new anti-DIC agent rTM is useful for safe driving of ECMO in patients with DIC.

Entities:  

Keywords:  Klebsiella oxytoca; Sepsis; extracorporeal membrane oxygenation; intensive care; intra-aortic balloon pumping; recombinant thrombomodulin alpha

Year:  2013        PMID: 24376326      PMCID: PMC3743625     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  10 in total

1.  Community-acquired Klebsiella oxytoca causing splenic abscess.

Authors:  Somsupha Kanjanauthai; Tony Kanluen
Journal:  Int J Infect Dis       Date:  2008-03-04       Impact factor: 3.623

2.  Adrenal hemorrhage associated with Klebsiella oxytoca bacteremia.

Authors:  K Hori; H Yasoshima; A Yamada; K Sakurai; E Ohkubo; A Kubota; K Uematsu; H Sasio; Y Mizokami; T Shimoyama
Journal:  Intern Med       Date:  1998-11       Impact factor: 1.271

3.  Survival after 385 min of cardiopulmonary resuscitation with extracorporeal membrane oxygenation and rewarming with haemodialysis for hypothermic cardiac arrest.

Authors:  Shuichi Hagiwara; Takuro Yamada; Kazumi Furukawa; Koichi Ishihara; Takuro Nakamura; Yoshio Ohyama; Jun'ichi Tamura; Kiyohiro Oshima
Journal:  Resuscitation       Date:  2011-03-31       Impact factor: 5.262

4.  Bacteremia due to Klebsiella oxytoca: clinical features of patients and antimicrobial susceptibilities of the isolates.

Authors:  R D Lin; P R Hsueh; S C Chang; Y C Chen; W C Hsieh; K T Luh
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

Review 5.  Extracorporeal membrane oxygenation and sepsis.

Authors:  Graeme Maclaren; Warwick Butt
Journal:  Crit Care Resusc       Date:  2007-03       Impact factor: 2.159

6.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

Review 7.  Percutaneous cardiopulmonary bypass for cardiac emergencies.

Authors:  Mark Kurusz; Joseph B Zwischenberger
Journal:  Perfusion       Date:  2002-07       Impact factor: 1.972

8.  Retrospective analysis of clinical and microbiological aspects of Klebsiella oxytoca bacteremia over a 10-year period.

Authors:  B N Kim; J Ryu; Y S Kim; J H Woo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-06-12       Impact factor: 3.267

9.  Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study.

Authors:  Kazuma Yamakawa; Satoshi Fujimi; Tomoyoshi Mohri; Hiroki Matsuda; Yasushi Nakamori; Tomoya Hirose; Osamu Tasaki; Hiroshi Ogura; Yasuyuki Kuwagata; Toshimitsu Hamasaki; Takeshi Shimazu
Journal:  Crit Care       Date:  2011-05-11       Impact factor: 9.097

10.  Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine.

Authors:  R Britt McILwain; Joseph G Timpa; Ashish R Kurundkar; David W Holt; David R Kelly; Yolanda E Hartman; Mary Lauren Neel; Rajendra K Karnatak; Robert L Schelonka; G M Anantharamaiah; Cheryl R Killingsworth; Akhil Maheshwari
Journal:  Lab Invest       Date:  2009-11-09       Impact factor: 5.662

  10 in total
  4 in total

1.  Klebsiella oxytoca: An emerging pathogen?

Authors:  Lavan Singh; M P Cariappa; Mandeep Kaur
Journal:  Med J Armed Forces India       Date:  2016-06-14

2.  Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence.

Authors:  Jing Yang; Haiyan Long; Ya Hu; Yu Feng; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2021-12-01       Impact factor: 50.129

3.  First Report of Klebsiella oxytoca Strain Simultaneously Producing NDM-1, IMP-4, and KPC-2 Carbapenemases.

Authors:  Juan Wang; Min Yuan; Hai Chen; Xia Chen; Yuanchun Jia; Xiong Zhu; Li Bai; Xue Bai; Séamus Fanning; Jinxing Lu; Juan Li
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

Review 4.  A review of sepsis-induced cardiomyopathy.

Authors:  Ryota Sato; Michitaka Nasu
Journal:  J Intensive Care       Date:  2015-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.